Sensirion Holding AG (STU:1Q3)
€ 81.3 (0%) Market Cap: 1.26 Bil Enterprise Value: 1.19 Bil PE Ratio: 41.75 PB Ratio: 3.65 GF Score: 74/100

Half Year 2026 Sensirion Holding AG Earnings Call Transcript

Aug 19, 2026 / 08:00AM GMT
Release Date Price: €82.6 (+0.24%)

Key Points

Positve
  • Sensirion Holding AG (XSWX:SENS) reported broad-based growth across all four end markets, with revenue up 7% in local currency despite a challenging prior-year comparison.
  • The company raised its full-year 2026 revenue guidance to CHF345-365 million, reflecting 8-14% growth in local currency, and expects EBITDA to land in the upper half of its mid-to-high teens range.
  • Gross margin expanded by 110 basis points to 52.6%, driven by operating leverage, favorable product mix, and efficiency programs, which helped absorb currency and raw material headwinds.
  • Net income surged 81% year-on-year to CHF18.9 million, supported by a normalized financial result, while operating cash flow rose 20% to CHF34 million.
  • Strategic growth initiatives are already contributing, including the first launch of battery management systems for EVs with a major European OEM and strong traction in gas chromatography and smart gas metering.
  • The balance sheet remains robust, with net cash increasing 14% to CHF81.7 million and an equity ratio of 80.8%, providing ample financial flexibility for organic growth and selective M&A.
Negative
  • Revenue in Swiss francs declined 3% due to the continued strength of the Swiss franc, which remains a significant headwind for reported figures.
  • The Americas region saw a decline in revenue, reflecting a strong prior-year base from A2L sensor front-loading, which has now normalized.
  • The industrial market, the company's largest at 54% of revenue, only grew 1% in local currency, as the normalization of A2L sales offset growth in other areas.
  • Lumiphase continues to face unresolved technical stability issues, with no significant strategic updates, and its equity-accounted losses remain a drag on financial results.
  • Medical market growth was partly attributed to precautionary inventory buildup by customers, raising uncertainty about the sustainability of demand in the second half.
  • Free cash flow conversion was relatively low at around 30% due to elevated capital expenditures, including CHF8.2 million for the second cleanroom in Stäfa, which will pressure near-term cash generation.
Lars Duennhaupt
Sensirion Holding AG - Director Investor Relations

Dear ladies and gentlemen, we would like to welcome you to Sensirion Holding AG conference call on the results of the half year 2026. From Sensirion, Marc von Waldkirch, our Chief Executive Officer; Martin Wirz, our Chief Financial Officer; and myself, Lars Dunnhaupt, Director Investor Relations, are present. In addition to the press release we issued earlier today, we will be referencing a presentation during today's call. The PDF of this presentation can be downloaded from the Sensirion Investor Relations page.

As we begin, please note that the conference call is being recorded and that all participants are set to mute. During the conference call, we will be making forward-looking statements regarding future events or the financial performance of the company that can involve certain risks and uncertainties. The company's actual results may differ from the projections described in such statements. So please take a minute to read it. Let's take a look at the agenda.

Marc will begin today by covering the highlights and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot